from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0038/-

LFCtreatmentdescriptionclass of inhibitor

-0.567

Amikacinug/mL Amikacintranslation

-0.260

Cap5-10ug/mL Capreomycintranslation

-1.744

Rox10-50 ug/mL Roxithromycintranslation

-0.791

SM2-5 ug/mL Streptomycintranslation

-1.064

Tet5-10 ug/mL Tetracyclinetranslation

0.327

Rif0.2-5ug/mL Rifampicintranscription

-0.333

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.660

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.855

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.775

CPZ10-50 ug/mL Chlorpromazinerespiration

0.606

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.036

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.642

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

3.338

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.225

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.283

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.183

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.942

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.869

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.388

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.031

KCN5-20 ug/mL Potassium cyaniderespiration

0.392

NaN30.2-2 mM Sodium aziderespiration

-0.776

Nigericin50 uM Nigericinrespiration

1.744

TRC10-150 ug/mL Triclosanrespiration

0.290

TRZ10-25 ug/mL Thioridazinerespiration

-0.879

Valinomycin0.5-10 uM Valinomycinrespiration

-1.349

ZnSO42 mM ZnSO4respiration

0.121

menadione6-10 ug/mL Menadionerespiration

0.031

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.430

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.437

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.274

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.243

NRP_1Non-replicating persistence stage 1dosRassociated

-0.625

Amp0.2mg/mL AmpicillincellWall

-0.270

Cephalexin20-100 ug/mL CephalexincellWall

-0.373

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.292

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.196

EMB10-20 ug/mL EthambutolcellWall

-1.281

Eta12-40 ug/mL EthionamidecellWall

-1.633

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.332

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.620

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.588

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.289

BZA0.12 mg/mL BenzamidearomaticAmides

0.061

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.437

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.052

H2O24 mM hydrogen peroxideDNAdamaging

-0.345

Levo10 ug/mL LevofloxacinDNAdamaging

-0.120

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.674

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.227

UVUV-irradiationDNAdamaging

-0.654

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.334

Antimycin12.5-50 ug/mL Antimycin A?

-0.879

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.375

PA_110-50 ug/mL Antitubercular compound PA-1?

0.042

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.598

PA8240.2-2 ug/mL PA-824?

1.362

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.109

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.613

Verapamil50 uM Verapamil?

-0.691

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.152

methoxatin10-20 ug/mL Methoxatin?